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RNase L-Independent Specific 28S rRNA Cleavage in Murine
Coronavirus-Infected Cells
SANGEETA BANERJEE, SUNGWHAN AN AIMIN ZHOU, ROBERT H. SILVERMAN,
AND SHINJI MAKINO
We characterized a novel 28S rRNA cleavage in cells infected with the murine coronavirus mouse hepatitis
virus (MHV). The 28S rRNA cleavage occurred as early as 4 h postinfection (p.i.) in MHV-infected DBT cells,
with the appearance of subsequent cleavage products and a decrease in the amount of intact 28S rRNA with
increasing times of infection; almost all of the intact 28S rRNA disappeared by 24 h p.i. In contrast, no specific
18S rRNA cleavage was detected in infected cells. MHV-induced 28S rRNA cleavage was detected in all
MHV-susceptible cell lines and all MHV strains tested. MHV replication was required for the 28S rRNA
cleavage, and mature cytoplasmic 28S rRNA underwent cleavage. In certain combination of cells and viruses,
pretreatment of virus-infected cells with interferon activates a cellular endoribonuclease, RNase L, that causes
rRNA degradation. No interferon was detected in the inoculum used for MHV infection. Addition of anti-
interferon antibody to MHV-infected cells did not inhibit 28S rRNA cleavage. Furthermore, 28S rRNA cleavage
occurred in an MHV-infected mouse embryonic fibroblast cell line derived from RNase L knockout mice. Thus,
MHV-induced 28S rRNA cleavage was independent of the activation of RNase L. MHV-induced 28S rRNA
cleavage was also different from apoptosis-related rRNA degradation, which usually occurs concomitantly with
DNA fragmentation. In MHV-infected 17Cl-1 cells, 28S rRNA cleavage preceded DNA fragmentation by at least
18 h. Blockage of apoptosis in MHV-infected 17Cl-1 cells by treatment with a caspase inhibitor did not block
28S rRNA cleavage. Furthermore, MHV-induced 28S rRNA cleavage occurred in MHV-infected DBT cells that
do not show apoptotic signs, including activation of caspase-3 and DNA fragmentation. Thus, MHV-induced
28S rRNA cleavage appeared to differ from any rRNA degradation mechanism described previously.
Coronaviruses are enveloped RNA viruses that cause gas-
trointestinal and upper respiratory tract illnesses in animals
and humans. These range, in severity, from very serious neo-
natal enteritis in domestic animals to the common cold in
humans. Although coronavirus infections are usually acute,
some coronaviruses cause persistent neurotropic infections in
animals (2, 38, 53). Among the coronaviruses, mouse hepatitis
virus (MHV) is one of the best characterized in terms of
pathogenesis and molecular biology. MHV causes various dis-
eases, including hepatitis, enteritis, and encephalitis in rodents
(6, 53). MHV contains a 32-kb-long, positive-sense, single-
stranded RNA genome (27, 29, 36) that encodes 11 open
reading frames, which are expressed through the production of
a genomic-size mRNA and six to eight species of subgenomic
mRNAs (26, 30). The identical leader sequence, about 70
nucleotides long, present at the 59 ends of all MHV mRNAs
and each MHV-specific protein, is translated from each sub-
genomic mRNA. Genomic-size mRNA encodes the most 59
gene, the 22-kb-long gene 1, which encodes the RNA polymer-
ase function (29). Expression of gene 1 and N protein, which is
encoded by the smallest mRNA, mRNA 7, is sufficient for
MHV RNA synthesis (24). MHV contains three envelope pro-
teins, S, M, and E. S protein binds to the coronavirus receptor
(7) and forms the characteristic coronavirus peplomer. M pro-
tein and E protein play an important role in the formation of
MHV envelope (4, 23, 52). MHV genomic RNA is associated
with N protein, forming a helical nucleocapsid (47).
Extensive morphological, physiological, and biochemical
changes occur in coronavirus-infected cells. Some of these
changes contribute to the damage of cells and tissues. Progress
in molecular biological and biochemical techniques has ad-
vanced our knowledge of the intracellular biochemical events
of coronavirus replication, whereas the specific basis for the
deleterious effects on host cells is not as well understood. Some
progress has been made regarding the mechanism of cell death
in coronavirus-infected cells; infection of coronavirus transmis-
sible gastroenteritis virus and MHV induces apoptosis in cer-
tain cells (1, 3, 8). As found for some lytic viruses (9, 11, 20,
21), host protein translation is inhibited (12, 42, 49, 50) but not
completely shut off in MHV-infected cells. Inhibition of host
protein synthesis is accompanied by an increase in MHV pro-
tein synthesis (42, 43, 44). Specific host mRNAs are degraded
in MHV-infected cells, while transcriptional upregulation of
some other host mRNAs occurs in MHV-infected cells (25).
The mechanism of selective MHV-specific protein synthesis,
which occurs concomitantly with host protein inhibition, in
infected cells is also poorly characterized, although it has been
suggested that MHV mRNAs containing 59-end leader se-
quences bind to N protein, forming a complex that may act as
a strong translation initiation signal (50, 51).
In this study, we described the specific cleavage of 28S rRNA
in MHV-infected cells; cleavage of 28S rRNA in coronavirus-
infected cells has not been described previously. There are a
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few examples of specific 28S rRNA cleavage: interferon (IFN)
secretion activates the cytoplasmic endoribonuclease, RNase
L, via activation of the 29,59-oligoadenylate (2-5A) system;
activated RNase L causes 28S and 18S rRNA cleavage in
murine cells and human cells (45, 46); in some human and rat
tumor cells, apoptosis triggers 28S rRNA cleavage when in-
duced by chemicals like actinomycin D or cyclic AMP (16, 17);
porcine reproductive and respiratory syndrome virus (PRRSV)
infection results in rRNA degradation that is related to nu-
cleosomal DNA cleavage and apoptosis (48); and rabbit retic-
ulocytes contain a membrane-associated endonuclease activity
that cleaves 28S rRNA (54). The present study demonstrates
that MHV-induced 28S rRNA cleavage is different from other
known rRNA cleavage events. The possible biological signifi-
cance of 28S rRNA cleavage in MHV infection is discussed.
MATERIALS AND METHODS
Viruses and cells. The plaque-cloned A59 strain of MHV (26), MHV-JHM
(33), and MHV-2 (22) were used. Mouse DBT cells (14) were used for the
propagation of virus stocks. DBT cells were maintained in minimal essential
medium supplemented with 8% heat-inactivated newborn calf serum. Mouse
L929 cells were used for IFN assay. 17Cl-1 cells (1) and mouse embryonic
fibroblasts (MEF cells) derived from wild-type (RNase L1/1) and RNase L
knockout (RNase L2/2) mice (55) were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum.
Northern (RNA) blotting. Northern blot analysis was performed using
[g-32P]ATP-labeled oligonucleotide probes as previously described (32). Oligo-
nucleotide probe 1 (59 CTAATCATTCGCTTTACCGG 39), which specifically
binds to nucleotides 1532 to 1551 from the 59 end of mouse 28S rRNA, was used
for the detection of 28S rRNA and its cleavage products. Oligonucleotide probes
2 (59 ATGCCCCCGGCCGTCCCTCT 39) and 3 (59 TAATGATCCTTCCGCA
GGTTCACC 39), which bind to nucleotides 921 to 940 and 1846 to 1870,
respectively, from the 59 end of mouse 18S rRNA, were used to detect 18S
rRNA. All hybridizations were performed at 60°C. To detect MHV-specific
RNAs, Northern blot analysis was performed using a digoxigenin (DIG)-labeled
random-primed probe (Boehringer), corresponding to the 39 end of MHV
genomic RNA, and visualized by using a DIG luminescence detection kit (Boehr-
inger) according to the manufacturer’s protocol.
Host protein synthesis analysis. Intracellular proteins were labeled as de-
scribed previously (23). Briefly, mock-infected and MHV-infected cells were
incubated in methionine-cysteine-free medium for 0.5 h before labeling. Cells
were labeled with Tran35S-label (75 mCi/ml; ICN) for 30 min at various times
postinfection (p.i.). Labeled cells were lysed in buffer (1% Triton X-100, 0.5%
sodium deoxycholate, and 0.1% sodium dodecyl sulfate [SDS] in phosphate-
buffered saline), and the postnuclear supernatant was separated by SDS-poly-
acrylamide gel electrophoresis (PAGE).
IFN assay. Functional IFN was detected by the vesicular stomatitis virus
(VSV) plaque reduction method as previously described (28). Briefly, confluent
DBT cells in 60-mm-diameter dishes were mock infected or infected with MHV-
A59 at a multiplicity of infection (MOI) of 10. At 12 h and 24 h p.i., supernatants
were harvested and irradiated with UV light (wavelength, 253 nm) for 12 min to
inactivate MHV. To 96-well clusters, seeded 24 h earlier with 4 3 104 mouse
L929 cells per well and containing 100 ml of complete medium (DMEM supple-
mented with 10% fetal bovine serum), 50-ml duplicate aliquots of mock-infected
or MHV-infected supernatant were added. Each sample was then serially three-
fold diluted 11 times. After 24 h of incubation at 37°C, 6 3 105 PFU of VSV, in
25 ml of complete medium, was added to each well. After another 24 h incubation
at 37°C, L929 cell viability was determined by counting the number of plaques in
each dilution. The dilution which yielded a 50% reduction in plaque number was
used to determine the IFN concentration in the original supernatant. Calcula-
tions were according to IFN concentrations based on National Institutes of
Health (NIH) standards for murine IFN-a and IFN-b.
Caspase-3 activity assay. Presence of activated caspase-3 was detected using a
caspase-3/CPP32 calorimetric protease assay kit (BioSource International Inc.,
Camarillo, Calif.); this assay system measures cleavage of the synthetic tetrapep-
tide Asp-Glu-Val-Asp (DEVD), linked to the chromophore p-nitroanilide, by
activated caspase-3. Cell extracts were prepared by solubilizing mock-infected or
MHV-A59-infected DBT cells at 4.5 and 8.5 h p.i. in a buffer consisting of 10 mM
Tris-HCl (pH 7.5), 10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, and 1%
Triton X-100. Cell extracts from DBT cells that were treated continuously in the
presence of 50 mM etoposide for 35.5 h were used as a positive control. As a
negative control, the 8.5-h-p.i. DBT lysate was incubated with 250 mM Z-DEVD-
fmk (Enzyme Systems, Livermore, Calif.), a caspase-3 inhibitor, for 30 min at
37°C. Aliquots of each sample, corresponding to 200 mg of protein, were mixed
with the reaction buffer {40 mM HEPES, 200 mM NaCl, 2 mM EDTA, 0.2%
3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 20%
glycerol, 10 mM dithiothreitol, 200 mM DEVD–p nitroanilide substrate} and
incubated in 96-well clusters. The amount of substrate hydrolyzed was measured
at an optical density of 405 nm. Background readings from cell lysates and buffers
were subtracted from both mock-infected and MHV-infected samples before
determining the fold increase in caspase-3 activation, calculated as (infected
lysate 1 substrate) 2 (infected lysate 2 substrate)/(mock lysate 1 substrate) 2
(mock lysate 2 substrate).
RESULTS
Cleavage of 28S rRNA in MHV-infected cells. We noticed
the appearance of a major band that migrated between the 28S
and 18S rRNAs after agarose gel electrophoresis of intracel-
lular RNA from MHV-A59-infected DBT cells. This band was
easily detected after ethidium bromide staining of the gels
(data not shown) or by methylene blue staining of intracellular
RNAs transferred to a nylon membrane (Fig. 1A). MHV sub-
genomic mRNA 6 migrated slightly faster than this major
band, and mRNA 7 comigrated with 18S rRNA. This band
appeared to be an RNA of non-MHV origin, as DNase treat-
ment did not affect it and the size differed from that of any of
the MHV subgenomic mRNAs. The size and abundance of the
band suggested that this RNA may be a cleavage product of
28S rRNA. We tested this possibility by Northern blot analysis
of intracellular RNAs from MHV-A59-infected DBT cells,
using an oligonucleotide (probe 1) that specifically hybridizes
with the mature mouse 28S rRNA at 1.5 kb from the 59 end
(Fig. 1B). This probe specifically hybridized with an intact 28S
rRNA and four additional minor bands from uninfected cells;
these minor bands most probably represented degraded RNAs
that were generated by the normal turnover of 28S rRNAs.
The same probe hybridized with intact 28S rRNA and a 3.2-
kb-long RNA (28S-CL1) from intracellular RNAs extracted
from MHV-A59-infected cells at 8 h p.i. Using two other
oligonucleotide probes, each of which hybridized with 28S
rRNA at 1.0 and 2.0 kb from the 59 end, we observed the same
28S rRNA cleavage (data not shown). Judging from the size
and amount of this 28S rRNA-related RNA, 28S-CL1 was the
cleavage product that we initially noticed (Fig. 1A). Parallel
Northern blots of the same RNA samples were probed with the
28S rRNA-specific oligonucleotide probe 1 and an MHV-spe-
cific probe that hybridizes with all of the MHV RNAs (Fig.
1B). The 28S-CL1 product differed in size from any MHV
mRNA, eliminating the possibility that it was the result of
nonspecific hybridization of probe 1 to MHV mRNAs.
A precise time course analysis of 28S rRNA cleavage during
MHV-A59 infection showed that a reduction in the amount of
28S rRNA was detectable at 7 h p.i. (Fig. 1C). Densitometric
scanning analysis showed a 60% decrease in the amount of
intact 28S rRNA from infected cells by 8 to 9 h p.i. compared
to uninfected cells. The amount of 28S rRNA decreased con-
tinuously, and 28S rRNA was hardly detectable by 24 h p.i. The
first cleavage product, 28S-CL1, appeared as a faint band as
early as 4 h p.i., and it increased substantially between 5 and 6 h
p.i. 28S-CL1 remained the major rRNA species from 9 to 12 h
p.i. Probe 1 also hybridized with four additional RNA bands,
2.8-kb-long 28S-CL2, 2.1-kb-long 28S-CL3, 2.0-kb-long 28S-
CL4, and 1.0-kb-long 28S-CL5, from MHV-A59-infected cells;
none of these smaller 28S rRNA cleavage products comigrated
with MHV mRNAs, and all were clearly visible by 12 h p.i.
28S-CL3 and 28S-CL4 were visible at 9 h p.i., and they accu-
mulated transiently until 16 h p.i. 28S-CL2 and 28S-CL5 ap-
peared around 12 h p.i. Late in infection, 28S-CL4 and 28S-
CL5 were the major cleavage products. By 24 h p.i., the
cleavage products had virtually disappeared and very little in-
tact 28S rRNA was present.
In contrast to the extensive cleavage of 28S rRNA in MHV-
A59-infected cells, Northern blot analysis of 18S rRNA, using
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two 18S rRNA-specific oligonucleotide probes, showed that
18S rRNA did not undergo cleavage in MHV-infected DBT
cells even late in infection (Fig. 1D). The amount of 18S rRNA
in MHV-A59-infected cells was similar to that in uninfected
cells until 12 h p.i., while the amount of intact 18S rRNA in
MHV-A59-infected cells decreased slightly at 16 h p.i. By 24 h
p.i. there was a decrease in the total amount of intact 18S rRNA;
the mechanism of reduction in the amount of 18S rRNA late in
FIG. 1. Characterization of 28S and 18S rRNAs in MHV-A59-infected cells. (A) DBT cells were mock infected (M) or infected with MHV-A59 (I) at an MOI of
10. At 8 h p.i., cytoplasmic RNA was extracted and a portion of the RNA was electrophoresed on a denaturing 1% agarose-formaldehyde gel. The RNA was blotted
onto a nylon membrane, which was stained with methylene blue. MHV-A59-specific mRNAs 1, 2, 3, and 6 are indicated by arrowheads. Intact 28S rRNA, 18S rRNA,
and the cleaved 28S rRNA product are indicated by arrows. (B) Cytoplasmic RNA was extracted from mock-infected DBT cells (M) or MHV-A59-infected DBT cells
at 8 h p.i. (8h). RNAs were electrophoresed on a denaturing 1% agarose-formaldehyde gel. The RNA was blotted onto a nylon membrane, which was cut into two
identical halves. One-half was probed with the 59-end-labeled oligonucleotide probe 1, which specifically binds to mouse 28S rRNA (lanes 1 and 2), and the other half
was probed with a random-primed DIG-labeled probe specific for MHV mRNAs (lanes 3 and 4). (C and D) Cytoplasmic RNA was extracted from MHV-A59-infected
DBT cells at various times p.i., as shown above the lanes. RNAs were electrophoresed on a denaturing gel and examined by Northern blot analysis, using the 28S
rRNA-specific probe 1 to detect 28S rRNA and its cleavage products (C) and a mixture of oligonucleotide probes 2 and 3 to detect 18S rRNA (D). The mock-infected
RNA sample (lanes 1 in panels C and D) was extracted at 24 h p.i.
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infection is not known. The amount of intact 18S rRNA re-
mained unchanged until 12 h p.i., and Northern blot analysis
detected no specific cleavage products; hence, we concluded
that 28S rRNA, but not 18S rRNA, underwent specific cleav-
age in MHV-A59-infected cells.
MHV replication was required for 28S rRNA cleavage. To
test whether binding of MHV to MHV receptors, or some
unidentified substances other than MHV present in the inoc-
ulum, induced 28S rRNA cleavage, the inoculum used in the
above experiments was exposed to UV light (wavelength, 253
nm) for 12 min prior to addition to DBT cells. MHV infectivity
of UV-irradiated samples was less than 1 PFU/0.2 ml. After
incubation for 1 h at 37°C, the inoculum was removed and the
cells were incubated for up to 8 h. No 28S rRNA cleavage was
detected in cells that underwent this treatment (Fig. 2), dem-
onstrating that binding of MHV to MHV receptors alone or to
unidentified substances which may have been present in the
inoculum did not induce 28S rRNA cleavage. Induction of 28S
rRNA cleavage required MHV replication.
Relationship between 28S rRNA cleavage and other MHV-
induced changes in infected cells. We compared the kinetics of
28S rRNA cleavage with other cellular changes that occurred
in MHV-infected cells. MHV-A59 infection in DBT cells in-
duces cell fusion mediated by S protein (7). MHV-A59-in-
duced cell fusion appeared 5 h p.i. Fused cells became 60%
and nearly 100% of the total cell population by 6 and 8 h p.i.,
respectively, but they did not start floating until 18 to 20 h p.i.
(data not shown). As shown in Fig. 1C, 28S rRNA cleavage
started earlier than the onset of MHV-A59-induced cell fusion.
MHV RNA synthesis peaks at 6 to 7 h p.i. (39). Amounts of
MHV RNAs are roughly constant from 8 to 10 h p.i. and then
decline at 11 h p.i. (39). A substantial increase in 28S-CL1 in
MHV-infected cells preceded the peak of MHV RNA synthe-
sis, and 28S rRNA cleavage continued beyond 12 h p.i. (Fig.
1C).
28S rRNA is an integral component of the large subunit of
the ribosome; cleavage of 28S rRNA may affect ribosome
structure or function and subsequently protein synthesis.
Hence we examined the relationship between 28S rRNA cleav-
age and protein synthesis in MHV-infected cells. MHV-A59-
infected DBT cells were labeled with Tran35S-label for 30 min
at different times p.i., and cell extracts were analyzed by SDS-
PAGE (Fig. 3). Synthesis of S, N, and M proteins was detect-
able at 5 h p.i.; these MHV structural proteins became major
proteins by 6 h p.i. Consistent with previous studies (12, 42, 49,
50), host protein synthesis was inhibited in MHV-infected cells
(Fig. 3); inhibition of host protein synthesis was seen around
7 h p.i. and proceeded further. As shown in Fig. 1C, 28S-CL1
appeared as a major cleavage product starting 5 h p.i. These
data showed that there was a slight lag period between host
protein synthesis inhibition and 28S-CL1 production. Thereaf-
ter, both 28S rRNA cleavage and host protein synthesis inhi-
bition continued as infection proceeded.
Cleavage of 28S rRNA after infection with different MHV
strains in different cell lines. We examined whether 28S rRNA
cleavage was confined to a particular cell type or MHV strain.
MHV-A59 infection of 17Cl-1 cells also produced all 28S
rRNA cleavage products; the kinetics of appearance of cleav-
age products and reduction in the amount of mature 28S
rRNA in MHV-A59-infected 17CL-1 cells were similar to re-
FIG. 2. Northern blot analysis of 28S rRNA after inoculation of UV-irradi-
ated MHV-A59. DBT cells were mock infected (M) or inoculated (I) with the
UV-irradiated MHV-A59 sample. Cytoplasmic RNA was extracted at 8 h p.i.,
and Northern blot analysis was performed with 59-end-labeled probe 1. The
arrow indicates intact 28S rRNA.
FIG. 3. Host protein synthesis inhibition in MHV-A59-infected DBT cells. DBT cells were mock infected (M) or infected with MHV-A59 (I) at an MOI of 10.
Culture medium was replaced with methionine-cysteine-free medium 30 min prior to each indicated time point. After 30 min of incubation, Tran35S-label was added
to the culture medium at a final concentration of 75 mCi/ml. Intracellular proteins were extracted after 30 min of incubation and analyzed by SDS-PAGE (12% gel).
Positions of MHV-A59 S, N, and M structural proteins are indicated by arrows.
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sults for MHV-infected DBT cells (data not shown). MHV-
JHM-infected DBT cells also induced the same 28S rRNA
cleavage products as found in MHV-A59-infected DBT cells,
but 28S rRNA cleavage was less prominent in MHV-JHM-
infected cells; the amount of intact 28S rRNA remaining in
MHV-A59-infected cells was much less than that in MHV-
JHM-infected cells at 24 h p.i. (data not shown). MHV-JHM-
induced 28S rRNA cleavage was slower than MHV-A59-in-
duced 28S rRNA cleavage, yet 28S-CL1 was clearly detectable
at 9 h p.i. in MHV-JHM-infected cells. Cleaved 28S rRNA
products were also less abundant than in MHV-A59-infected
cells. We detected no major differences in the patterns of 28S
rRNA cleavage in MHV-JHM-infected 17CL-1 cells and
MHV-JHM-infected DBT cells. Production of infectious
MHV from MHV-JHM-infected cells is about 10 times lower
than that from MHV-A59-infected cells, and the amount of
MHV-specific RNAs in MHV-JHM-infected cells is also lower
than that in MHV-A59-infected cells (data not shown). A
lower level of MHV-JHM replication efficiency in infected
cells may be related to less efficient 28S rRNA cleavage.
We used a nonfusogenic MHV strain, MHV-2, to test
whether MHV-induced cell fusion was required for 28S rRNA
cleavage. The same 28S rRNA cleavage products accumulated
in MHV-2-infected DBT cells (data not shown). Kinetics of
28S rRNA cleavage in MHV-2-infected DBT cells was similar
to that of MHV-JHM-infected DBT cells. These data demon-
strated that MHV-induced 28S rRNA cleavage was not re-
stricted to any particular MHV strain or MHV-susceptible cell
line.
Evidence for cleavage of mature cytoplasmic 28S rRNA in
MHV-infected cells. Mature cytoplasmic 28S rRNA is gener-
ated from a precursor 45S rRNA; 45S rRNA undergoes spe-
cific cleavages to produce 28S rRNA, 18S rRNA, and other
small rRNAs in the nucleolus (37). After processing, 28S
rRNA associates with ribosomal proteins to form the large
subunit, which is then transported to the cytoplasm (37). Ac-
cumulation of 28S rRNA cleavage products in MHV-infected
cells may be the result of cleavage of mature cytoplasmic 28S
rRNA or of aberrant rRNA processing, which takes place in
the nucleolus. To examine the possibility that mature cytoplas-
mic 28S rRNA is cleaved in MHV-infected cells, we first de-
termined the time taken by the precursor rRNA to be trans-
ported from the nucleolus to the cytoplasm. DBT cells at 50%
confluency were incubated in the presence of [3H]uridine (60
mCi/ml). After 16 h of incubation, the culture medium was
replaced with growth medium lacking [3H]uridine. The labeled
rRNAs were chased in medium without [3H]uridine. At vari-
ous times during this chase period, intracellular RNA was
extracted and analyzed on a 1% agarose-formaldehyde gel.
Labeled mature 28S and 18S rRNAs were detected in the
cytoplasm after a 5.5- to 12-h chase (data not shown). To test
whether mature cytoplasmic 28S rRNA was cleaved in MHV-
infected cells, 50% confluent DBT cells were incubated in the
presence of [3H]uridine (100 mCi/ml). After 16 h of incubation,
the culture medium was replaced with growth medium lacking
[3H]uridine and chased for another 13 h; processing and trans-
portation of 28S rRNA were completed during this chase pe-
riod. Cells were then mock infected or infected with MHV-
A59. After 1 h of virus adsorption, the inoculum was removed
and cells were incubated in a medium containing actinomycin
D (5 mg/ml) to prevent transcription of host RNAs, including
rRNAs. Cytoplasmic RNA was extracted at 8 h p.i. and ana-
lyzed by electrophoresis on a 1% denaturing agarose-formal-
dehyde gel (Fig. 4). Both 28S and 18S rRNAs were seen in
mock-infected cells, while 28S-CL1 and a reduced level of 28S
rRNA were detected in MHV-infected cells. Since the majority
of intact rRNAs were radiolabeled and transported to the
cytoplasm prior to MHV infection, and only cytoplasmic RNAs
were extracted in this experiment, rRNAs detected in this
study should represent cytoplasmic rRNAs that were made
prior to MHV infection. Reduction of intact 28S rRNA and
the presence of 28S-CL1 in MHV-infected cells demonstrated
that MHV infection induced cleavage of mature cytoplasmic
28S rRNA that was made prior to MHV infection. Thus, cy-
toplasmic 28S rRNA, which is part of the large subunit, was
cleaved during MHV infection.
Independence of MHV-induced 28S rRNA cleavage from
2-5A system-mediated rRNA degradation. In certain combina-
tion of viruses and cells, pretreatment of cells with IFN and
subsequent viral infection result in rRNA degradation (45).
This rRNA degradation is mediated by the 2-5A system (45,
46), in which IFN upregulates the enzyme 2-5A synthetase,
which synthesizes 2-5A molecules. These 2-5A moieties are
highly unstable and are rapidly degraded by phosphatases. In
the presence of viral double-stranded RNAs, 2-5A binds and
activates the endoribonuclease, RNase L. RNase L activation
is localized and serves to cleave viral mRNAs, thus inhibiting
viral replication and limiting viral spread. At high 2-5A con-
centrations, RNase L activation leads to extensive degradation
of rRNAs (31).
We examined whether the 28S rRNA cleavage in MHV-
infected cells was due to activation of the 2-5A system. RNase
L-mediated rRNA degradation usually requires treatment of
cells with IFN prior to virus infection (45). MHV-induced 28S
rRNA cleavage occurred in the absence of IFN pretreatment;
therefore, it was less likely that the conventional 2-5A system
was mediating MHV-induced 28S rRNA cleavage. However,
the MHV sample used for virus inoculation could contain IFN
secreted from infected cells. Subsequent infection using that
inoculum would then expose the cells to IFN during virus
adsorption. Such a brief exposure of cells to IFN and the
subsequent replication of MHV may be sufficient to activate
the 2-5A system in the infected cell. We tested this possibility
by examining the production of IFN from MHV-infected DBT
cells, as all MHV stocks used for virus inoculation were grown
in DBT cells. A classical biological assay for IFN, which uses
the susceptibility of VSV replication in IFN-pretreated L929
cells (28), was used to detect biologically active IFN in MHV-
infected supernatants. VSV replication in L929 cells was very
sensitive to pretreatment with a mixture of IFN-a and IFN-b
NIH standards, as no VSV plaques formed at moderate dilu-
FIG. 4. Evidence for the cleavage of mature cytoplasmic 28S rRNA in MHV-
infected DBT cells. DBT cells at a low confluency were labeled with [3H]uridine
for 16 h and then chased, in a medium lacking isotope, for 13 h. Cells were then
mock infected (M) or infected with MHV-A59 (I) at an MOI of 10. After
adsorption for 1 h, cells were incubated in the presence of actinomycin D (5
mg/ml), and cytoplasmic RNA was extracted at 8 h p.i. Cytoplasmic RNAs were
electrophoresed on a 1% denaturing gel. The gel was washed and enhanced prior
to autoradiography. The gel was exposed at 280°C for 60 days. The arrows
indicate intact 28S rRNA, 28S-CL1, and 18S rRNA.
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tions of these NIH standards. In contrast, supernatant from
MHV-infected and mock-infected cells failed to protect L929
cells from VSV replication (data not shown), suggesting that
MHV-infected culture fluid contained no or an undetectable
level of biologically active IFN.
Next we examined the possibility that the autocrine pathway
of IFN action (40) could mediate MHV-induced 28S rRNA
cleavage. If very low levels of IFN mediate MHV-induced 28S
rRNA cleavage through the autocrine pathway, then neutral-
izing the putative IFN which is secreted into MHV-infected
culture fluid should block this pathway. After adsorption of
MHV-A59, DBT cells were incubated in the presence of an
anti-mouse IFN-a and -b rabbit antibody mixture (20% IFN-
a–80% IFN-b; 30 U/ml; NIAID catalog no. G024-501-568).
This amount of anti-IFN antibodies can neutralize 3,000 U of
IFN. This concentration of antibodies was more than enough
to neutralize any IFN that might be produced from MHV-
infected cells, because the IFN bioassay showed that less than
3 U of IFN per ml may be secreted by MHV-infected cells.
Northern blot analysis of intracellular RNAs that were ex-
tracted at 8 h p.i. showed that incubation of MHV-infected
cells with anti-IFN antibodies did not block 28S rRNA cleav-
age (Fig. 5). Taken together, these data demonstrated that IFN
was not involved in 28S rRNA cleavage in MHV-infected cells.
We tested yet another possibility, that MHV infection di-
rectly activates RNase L in the absence of IFN. We used
RNase L1/1 and RNase L2/2 MEF cells to examine this pos-
sibility. If RNase L plays a vital role in 28S rRNA cleavage in
MHV-infected cells, 28S rRNA cleavage should not occur in
MHV-infected RNase L2/2 cells. We conducted a [32P]2-5A
cross-linking assay (35) to confirm the absence of RNase L in
RNase L2/2 cells; our data unambiguously showed the lack of
RNase L in RNase L2/2 cells and the presence of RNase L in
RNase L1/1 cells (data not shown).
One-step MHV-A59 growth curve analysis showed that
MHV replicated with similar kinetics, with maximum virus titer
at about 24 h p.i. in both RNase L1/1 and RNase L2/2 cell
lines. The maximum MHV titer in both cell lines was about 5
to 10 times lower than that in DBT cells. Immunofluorescence
studies using an anti-N protein monoclonal antibody showed
that in both cell lines approximately 15% cells supported MHV
replication after MHV inoculation at an MOI of 10 (data not
shown); we do not know why only 15% of cells supported
MHV replication. Both cell lines showed no apparent cyto-
pathic effects, including cell fusion, after MHV-A59 infection.
To determine whether MHV-induced 28S rRNA cleavage oc-
curred in the absence of RNase L expression, RNase L1/1 and
RNase L2/2 cells were infected with MHV-A59 at an MOI of
10. Intracellular RNA was extracted at various times p.i., and
28S rRNA cleavage was examined by Northern blot analysis.
Cleavage of 28S rRNA occurred in both cell lines (Fig. 6). The
sizes of the 28S rRNA cleavage products in both cell lines were
the same as those found in MHV-infected DBT cells. The
amount of intact 28S rRNA did not decrease drastically in
either type of MEF cells after MHV infection. This was not
surprising, as only 15% of each cell type was infected with
MHV; 28S rRNA cleavage did not occur in uninfected cells.
Blocking apoptosis did not affect MHV-induced 28S rRNA
cleavage. There have been some reports of rRNA degradation
occurring in apoptotic cells. Treatment of certain tumor cells
with chemical inducers of apoptosis, e.g., actinomycin D and
cyclic AMP, causes 28S rRNA degradation coincident with
DNA fragmentation, which is a characteristic change found in
apoptotic cells (16, 17). PRRSV infection of susceptible cells
causes apoptosis, characterized by DNA fragmentation, con-
comitant with cleavage of both 18S and 28S rRNAs (48).
Apoptosis is induced in MHV-infected 17Cl-1 cells but not
in MHV-infected DBT cells (1). Nevertheless 28S rRNA cleav-
age occurred in both DBT cells (Fig. 1) and 17Cl-1 cells (data
not shown). Furthermore, a DNA ladder, representing apo-
ptotic DNA fragmentation, is detected at about 24 h p.i. in
MHV-infected 17Cl-1 cells (1), while significant 28S rRNA
cleavage occurred much earlier, around 5 h p.i. (data not
shown). These differences signify that 28S rRNA cleavage de-
tected in MHV-infected cells and rRNA degradation associ-
ated with apoptosis are not identical, yet MHV-induced 28S
rRNA cleavage and apoptosis may be related. A possible re-
lationship between MHV-induced 28S rRNA cleavage and
apoptosis was examined.
First we examined whether induction of apoptosis in DBT
cells resulted in 28S rRNA cleavage, i.e., whether 28S rRNA
cleavage is a typical change that occurs in apoptotic DBT cells.
DBT cells at 50% confluency were incubated in medium con-
taining 2% serum for 18 h. After addition of 50 mM etoposide,
cells were incubated for 33 h, and then internucleosomal DNA
(13) and intracellular RNA were extracted. Etoposide treat-
ment of DBT cells resulted in DNA ladder formation, dem-
onstrating that DBT cells can die by apoptosis. However, no
specific cleavage of either 18S or 28S rRNA occurred (data not
FIG. 6. MHV-induced 28S rRNA cleavage in RNase L1/1 (A) and RNase
L2/2 (B) MEF cells. RNase L1/1 (RNL1/1) and RNase L2/2 (RNL2/2) MEF
cells were mock infected (M) or infected with MHV-A59 (I) at an MOI of 10.
Cytoplasmic RNA was extracted at the indicated times and electrophoresed on
a 1% denaturing gel. Cleavage of 28S rRNA was examined by Northern blot
analysis using 59-end-labeled probe 1.
FIG. 5. Effect of anti-mouse IFN antibodies on MHV-induced 28S rRNA
cleavage. DBT cells were mock infected (lanes 3 and 4) or infected with MHV-
A59 (lanes 1 and 2) at an MOI of 10. After virus adsorption for 1 h, cells were
incubated in the absence (lanes 1 and 3) or presence of 30 U of rabbit anti-mouse
IFN antibodies (Ab) per ml (lanes 2 and 4). Cytoplasmic RNA was extracted at
8 h p.i., and 28S rRNA cleavage was examined by Northern blot analysis using
59-end-labeled probe 1.
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shown), indicating that 28S rRNA cleavage was not a common
apoptotic change in DBT cells that underwent apoptosis.
Although MHV-infected DBT cells showed no apoptotic
signs, certain steps of the apoptotic process may occur in
MHV-infected DBT cells but apoptosis may be blocked.
Caspase-3 plays a central role in caspase-dependent apoptosis
(5, 34). We wondered whether caspase-3 was activated in
MHV-infected DBT cells; caspase-3 may be activated early in
MHV-infected DBT cells, and activated caspase-3 may trigger
28S rRNA cleavage. To examine this possibility, DBT cells
were mock infected or infected with MHV-A59 at an MOI of
10, and cell lysates were prepared at 4.5 and 8.5 h p.i. Etopo-
side-treated DBT cells were used as a positive control.
Caspase-3 activity assay demonstrated a fourfold increase in
caspase-3 activation in etoposide-treated DBT cells, with no
caspase-3 activation in MHV-infected DBT cells at 4.5 and
8.5 h p.i. These data suggested that 28S rRNA cleavage was
upstream of the activation of caspase-3 or not regulated by
caspase-3.
MHV-infected 17Cl-1 cells die by apoptosis (1). Treatment
of MHV-infected 17Cl-1 cells with the irreversible, cell-perme-
able caspase-3 inhibitor Z-DEVD-fmk inhibits MHV-induced
apoptosis without suppressing MHV growth (1). If MHV-in-
duced 28S rRNA cleavage is an event downstream of caspase-3
activation, then Z-DEVD-fmk treatment of MHV-infected
17Cl-1 cells would inhibit MHV-induced 28S rRNA cleavage.
For 2 h prior to MHV-A59 infection and after MHV-A59
infection, 17Cl-1 cells were incubated with 80 mM Z-DEVD-
fmk, because apoptosis is blocked in MHV-infected 17CL-1
cells under this experimental condition (1). Control samples
were incubated with dimethyl sulfoxide, which was used to
dissolve Z-DEVD-fmk. As expected, a DNA ladder assay at
24 h p.i. showed that Z-DEVD-fmk treatment blocked apo-
ptosis, while MHV-infected cells that were incubated with di-
methyl sulfoxide showed clear DNA fragmentation (data not
shown). Northern blot analysis of intracellular RNAs that were
extracted at 8 and 16 h p.i. showed that Z-DEVD-fmk treat-
ment had no effect on MHV-induced 28S rRNA cleavage (Fig.
7). Inhibition of caspase-3 activity in MHV-infected 17Cl-1
cells did not block or delay 28S rRNA cleavage, indicating that
MHV-induced 28S rRNA cleavage was not an event down-
stream of caspase-3 activation.
In summary, triggering apoptosis by etoposide treatment in
DBT cells did not cause any 28S rRNA cleavage. Conversely,
blocking apoptosis by Z-DEVD-fmk treatment in MHV-in-
fected 17Cl-1 cells did not block MHV-induced 28S rRNA
cleavage. Also, no activation of caspase-3 was detected in
MHV-infected DBT cells. These data strongly indicated either
that 28S rRNA degradation was occurring upstream of
caspase-3 activation or that apoptosis induction and 28S rRNA
cleavage occurred via two independent pathways.
DISCUSSION
Comparison of MHV-induced 28S rRNA cleavage and other
28S rRNA cleavage mechanisms. In this study, we report a
novel MHV-induced 28S rRNA cleavage. The MHV-induced
rRNA cleavage occurred only in 28S rRNA, not in 18S rRNA;
generation of 28S rRNA cleavage products of specific sizes
argues against a random RNase activation, which would result
in smeared bands of degraded rRNAs, with no preference for
18S rRNA or 28S rRNA. The cleavage products appeared
around 4 h p.i., with further cleavage products appearing with
increasing times of infection. Mature cytoplasmic 28S rRNA, a
part of the 60S large ribosomal subunit, underwent cleavage.
UV-inactivated MHV failed to induce 28S rRNA cleavage,
demonstrating that the binding of virus to the cell surface
receptor or unidentified substances which may be present in
the inoculum did not induce 28S rRNA cleavage. Specific
cleavage of 28S rRNA required ongoing MHV replication.
Currently, however, we do not know which step of the viral life
cycle or specific viral factor(s) causes this 28S rRNA cleavage.
MHV infection to all susceptible cell lines, using several dif-
ferent MHV strains, induced 28S rRNA cleavage; MHV-in-
duced 28S rRNA cleavage was independent of virus-induced
cytopathic effect. Kyuwa et al. reported a 50% decrease in
intact 28S rRNA at 12 h p.i. in MHV-JHM-infected J774.1
BALB/c monocytic cells (25). Their data are consistent with
our observation of reduced amount of intact 28S rRNA with
increasing times of MHV infection.
One of the known mechanisms of rRNA degradation is
through the activation of RNase L, a cellular endoribonucle-
ase, activated by the 2-5A system. We showed that MHV-
induced 28S rRNA cleavage was independent of the 2-5A
system and RNase L activation. Namely, IFN was undetectable
in the inoculum used for MHV infection. Also, neutralization
of putative IFN in the culture fluid from MHV-infected cells by
anti-IFN antibodies did not affect MHV-induced 28S rRNA
cleavage. Furthermore, MHV infection of RNase L2/2 MEF
cells induced a pattern of 28S rRNA cleavage similar to that
induced in RNase L1/1 MEF cells.
Apoptosis-associated rRNA cleavage is another known
mechanism of rRNA degradation; DNA fragmentation and
RNA fragmentation are usually temporally linked in this type
of rRNA cleavage (16, 17). The only report of rRNA degra-
dation during viral infection is during PRRSV infection or
expression of the PRRSV p25 gene product (48). In both cases,
rRNA degradation is coincident with DNA fragmentation and
other morphological features of apoptosis. MHV-induced 28S
rRNA cleavage differed from apoptosis-related rRNA degra-
dation and PRRSV-induced rRNA degradation. MHV-in-
duced 28S rRNA cleavage occurred in DBT cells that do not
undergo apoptosis (1), and no activated caspase-3 was detected
in MHV-infected DBT cells. MHV-infected 17Cl-1 cells un-
dergo caspase-dependent apoptosis, where DNA fragmenta-
FIG. 7. Effect of the caspase inhibitor Z-DEVD-fmk on MHV-induced 28S
rRNA cleavage. Mouse 17Cl-1 cells were incubated in serum-free DMEM (lanes
1, 4, 5, and 8) or 80 mM Z-DEVD-fmk (lanes 2, 3, 6 and 7) for 2 h prior to MHV
infection. Cells were then mock infected (lanes 1, 2, 5, and 6) or infected with
MHV-A59 (lanes 3, 4, 7, and 8) at an MOI of 10. After adsorption, cells were
incubated in the presence (lanes 2, 3, 6, and 7) or absence (lanes 1, 4, 5, and 8)
of 80 mM Z-DEVD-fmk. Cytoplasmic RNA was extracted at the indicated times.
Cleavage of 28S rRNA was examined by Northern blot analysis using 59-end-
labeled probe 1.
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tion is detected at about 24 h p.i. (1), whereas MHV-induced
28S rRNA cleavage was detected much earlier. Treatment of
MHV-infected 17Cl-1 cells with the caspase-3 inhibitor Z-
DEVD-fmk did not affect 28S rRNA cleavage, whereas this
treatment did inhibit DNA fragmentation; hence, inhibition of
apoptosis did not block 28S rRNA cleavage. These data argue
against the involvement of an activated caspase-3 and the trig-
gering of apoptosis in inducing 28S rRNA cleavage. MHV-
induced 28S rRNA cleavage was probably an event indepen-
dent of apoptosis or, if related, was upstream of the activation
of caspase-3 and a very early event in MHV infection.
Wreschner et al. (54) have reported the presence in rabbit
reticulocyte lysates of a membrane-bound RNase M which is
inactivated during maturation of reticulocytes to erythrocytes.
RNase M cleaves 28S rRNA. No such RNase has been found
in DBT or 17Cl-1 cells, and since these are immortalized,
transformed cell lines, the presence of a developmentally reg-
ulated RNase is questionable. Specific 28S rRNA cleavage and
DNA fragmentation are seen in rat brains during traumatic
brain injury (10), and the authors concluded that the rRNA
fragmentation in their system may be related to either necrosis
or apoptosis. Cleavage of 28S rRNA by RNase M or during rat
brain injury generated 28S rRNA cleavage products that dif-
fered in size from the 28S rRNA cleavage products found in
MHV-infected cells. Thus, MHV-induced 28S rRNA specific
cleavage appeared to be different from other reported rRNA
degradations.
The mechanism of MHV-induced 28S rRNA cleavage. Al-
though RNase L was not responsible for MHV-induced 28S
rRNA cleavage, it is possible that such a cleavage was the
result of activation of another RNase of cellular or viral origin.
Others have reported the degradation of few cellular mRNAs
during MHV infection (12, 25, 49). Therefore, it is conceivable
that the RNase responsible for cleaving 28S rRNA may also
degrade these host mRNAs, as the reduction of cellular
mRNAs appears to be, at least in part, responsible for the host
protein synthesis inhibition in MHV-infected cells (12). MHV-
encoded RNase activity has not been demonstrated. Another
possibility is that the structure of 60S ribosome may be altered
by binding of unidentified MHV factors or host factors which
are induced by infection in MHV-infected cells. This putative
structural alteration may allow a cellular or viral RNase to
access specific regions of 28S rRNA, resulting in specific cleav-
age of 28S rRNA.
MHV-induced 28S rRNA cleavage and protein translation.
28S rRNA is an integral component of 60S ribosome, whose
major function is protein translation. Hence, MHV-induced
28S rRNA cleavage may affect protein synthesis. Indeed, con-
sistent with previous studies (12, 42, 49, 50), host protein trans-
lation was severely inhibited but not completely shut off in
MHV-infected cells (Fig. 3). It is tempting to speculate that
ribosomes containing the cleaved 28S rRNA may not be able
to form polysomes or may be functionally inactive in protein
synthesis. In that case, MHV-specific protein synthesis may
take place on polysomes containing intact 28S rRNAs. This
possibility is consistent with the finding that the amount of 80S
monosome which is not involved in protein translation in-
creased in MHV-infected cells (12), and both MHV and host
proteins were poorly synthesized late in MHV infection, when
only a minute amount of intact 28S rRNA was detected (Fig.
1C). Alternatively, most host protein synthesis does not occur
on ribosomes containing cleaved 28S rRNA, while MHV-spe-
cific proteins are preferentially synthesized on ribosomes con-
taining the cleaved 28S rRNA species. 28S-CL1, the first cleav-
age product, appeared early in infection and remained a major
stable rRNA species until 12 h p.i. (Fig. 1C). It is conceivable
that ribosomes containing 28S-CL1 are functional but struc-
turally altered to better translate the increasing amounts of
MHV-specific mRNAs, which begin to accumulate from 5 h
p.i. Tahara et al. reported that chimeric mRNAs containing the
MHV leader sequence upstream of the human a-globin region
translate more efficiently than the authentic human a-globin
mRNA in extracts from MHV-infected cells, whereas this
translational enhancement is not seen in extracts from unin-
fected cells (50). Recent studies on translation analysis of bo-
vine coronavirus (BCV) mRNAs also showed that the pres-
ence of BCV leader sequence in chimeric mRNAs increases
their translation activity in BCV-infected cells (41). Since
MHV N protein binds to the leader sequence (51), Tahara et
al. speculated that binding of N protein to the 59 end of the
MHV leader sequence may augment translation efficiency in
MHV-infected cells (51). Presence of MHV leader sequence at
the 59 ends of MHV mRNAs and N protein binding may allow
MHV protein synthesis in ribosomes containing cleaved 28S
rRNAs. There is yet another possibility, that 28S rRNA cleav-
age does not affect the translational activity of ribosomes;
ribosomes containing cleaved 28S rRNAs may be biologically
active for translation of both host and MHV proteins. In that
case, the inhibition of host protein synthesis in MHV-infected
cells is mediated by some other, unidentified mechanism(s).
Biological significance of MHV-induced 28S rRNA cleavage.
What is the biological significance of a specific 28S rRNA
cleavage occurring early in MHV infection? It has been pro-
posed that 28S rRNAs may serve as cytoplasmic “biosensors”
regulating cellular processes (18, 19). In apoptosis-related 28S
rRNA cleavage, the cleavages occur at specific sites within
rRNA D domains (17). Although the biological function of D
domains of 28S rRNA has not been established, Houge and
Doskeland speculated that various proapoptotic signal trans-
duction pathways, e.g., those involving phosphorylation and/or
proteolysis, can convert the D domain from a passive to an
active state (15). If a sufficient number of ribosomes are in the
active state, the threshold for apoptosis is exceeded. Secondary
to the postulated D-domain modulations, apoptotic rRNA
cleavage may inactivate the D domains or liberate the cleaved
28S rRNA fragments, which may have additional biological
effects (15). Iordanov et al. described other cellular responses
to changes in the status of 28S rRNA, reporting that damage at
a specific loop of the 28S rRNA, or binding of peptidyltrans-
ferase inhibitors to the adjacent peptidyltransferase center of
the 28S rRNA, induced a ribotoxic stress response (19). This
response involves the activation of the stress-activated protein
kinase/c-Jun NH2-terminal kinase, the p38 mitogen-activated
protein kinase, and the transcriptional induction of immediate-
early genes such as c-fos and c-jun (18, 19). The signal trans-
duction cascade promotes either cell recovery and survival
after cellular damage or apoptotic cell death (reference 19 and
references therein). MHV-induced 28S rRNA cleavage may
have a similar biological consequence as ribotoxic stress re-
sponse; MHV-induced 28S rRNA cleavage may activate a sig-
nal transduction pathway(s), which may result in the alteration
of the cellular environment. The altered environment may
suppress MHV replication as a cellular countermeasure
against MHV infection. Alternatively, MHV may have evolved
to trigger a signal transduction pathway to enhance its repli-
cation; such an altered cellular environment, triggered by the
MHV-induced 28S rRNA cleavage-mediated transduction
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